Projects funded by the NCN
Comparative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) and olanzapine on the cognitive dysfunction measured in animal models of schizophrenia.
2017/25/B/NZ7/01096
Keywords:
schizophrenia 1MeTIQ antipsychotic activity
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 10
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 067 965 PLN
Project start date (Y-m-d): 2018-01-19
Project end date (Y-m-d): 2021-10-18
Project duration:: 45 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.